Sarcopenia as a predictor of surgical morbidity in advanced ovarian cancer patients

被引：0
|
作者：
Kumar, A. [1 ]
Moynagh, M. [1 ]
Cliby, B. A. [2 ]
McGree, M. [2 ]
Young, P. [1 ]
Bakkum-Gamez, J. N. [2 ]
Langstraat, C. L. [2 ]
Dowdy, S. C. [2 ]
Jatoi, A. [2 ]
Mariani, A. [2 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷
关键词：
D O I：
10.1016/j.ygyno.2015.01.122
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
120
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [31] UNCHANGED MORBIDITY DESPITE INCREASED SURGICAL RADICALITY IN CYTOREDUCTIVE SURGERY FOR AN ADVANCED STAGE EPITHELIAL OVARIAN CANCER
    Kaufmann, A.
    Laios, A.
    Broadhead, T.
    Hutson, R.
    Nugent, D.
    Thangavelu, A.
    Theophilou, G.
    De Jong, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A455 - A455
  • [32] SURVIVAL OUTCOME AND SURGICAL MORBIDITY ANALYSIS OF INTERVAL CYTOREDUCTIVE SURGERY PERFORMED FOR ADVANCED EPITHELIAL OVARIAN CANCER
    Rema, P. N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A512 - A512
  • [33] Personalized surgical therapy for advanced ovarian cancer
    Nick, A. M.
    Coleman, R. L.
    Ramirez, P. T.
    Schmeler, K. M.
    Soliman, P. T.
    Lu, K. H.
    Burzawa, J. K.
    Sood, A. K.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 10 - 10
  • [34] Critique of surgical cytoreduction in advanced ovarian cancer
    Covens, AL
    GYNECOLOGIC ONCOLOGY, 2000, 78 (03) : 269 - 274
  • [35] Importance of surgical aggressiveness in advanced ovarian cancer
    Aletti, GD
    Cliby, WA
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2397 - 2397
  • [36] Sarcopenia as a predictor of overall survival in patients with ovarian cancer undergoing chemotherapy: A systematic review and meta-analysis
    Damay, V.
    Kwenandar, F.
    Japar, K. V.
    Hariyanto, T. I.
    Wibisono, P.
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1338 - S1338
  • [37] Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy
    Staley, S. Allison
    Tucker, Katherine
    Newton, Meredith
    Ertel, Michelle
    Oldan, Jorge
    Doherty, Irene
    West, Lindsay
    Zhang, Yingao
    Gehrig, Paola A.
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 695 - 700
  • [38] Sarcopenia as a predictor of chemotherapy toxicity in patients with ovarian cancer receiving platinum and taxane-based chemotherapy.
    Tucker, Katherine
    Staley, Stuart-Allison Moffat
    Newton, Meredith
    Ertel, Michelle
    Zhang, Yingao
    Doherty, Irene
    Gehrig, Paola A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Surgical morbidity and clinical outcomes in ovarian cancer - the role of obesity
    Smits, A.
    Lopes, A.
    Das, N.
    Kumar, A.
    Cliby, W.
    Smits, E.
    Bekkers, R.
    Massuger, L.
    Galaal, K.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (02) : 300 - 308
  • [40] Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?
    Horisberger, K.
    Hofheinz, R. D.
    Palma, P.
    Volkert, A. K.
    Rothenhoefer, S.
    Wenz, F.
    Hochhaus, A.
    Post, S.
    Willeke, F.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (03) : 257 - 264
12345